Correlation between post-vaccination titres of anti-Spike antibodies and protection against breakthrough SARS-CoV-2 infection in 7530 UK adults
G. Vivaldi (London, United Kingdom), D. Jolliffe (London, United Kingdom), S. Faustini (Birmingham, United Kingdom), H. Holt (London, United Kingdom), M. Talaei (London, United Kingdom), F. Tydeman (London, United Kingdom), A. Richter (Birmingham, United Kingdom), S. Shaheen (London, United Kingdom), A. Martineau (London, United Kingdom)
Source: International Congress 2022 – Diagnosis, prevention and management of infectious respiratory diseases
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Vivaldi (London, United Kingdom), D. Jolliffe (London, United Kingdom), S. Faustini (Birmingham, United Kingdom), H. Holt (London, United Kingdom), M. Talaei (London, United Kingdom), F. Tydeman (London, United Kingdom), A. Richter (Birmingham, United Kingdom), S. Shaheen (London, United Kingdom), A. Martineau (London, United Kingdom). Correlation between post-vaccination titres of anti-Spike antibodies and protection against breakthrough SARS-CoV-2 infection in 7530 UK adults. 2455
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|